VAERS reports by lot

GSK Varicella/Shingles lot 4G5HX: VAERS reports

89 VAERS reports list lot 4G5HX as a GSK Varicella/Shingles vaccine, received between 2019-03-01 and 2021-03-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
89
Reports
2%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8931%
Injection-site / Local reaction7827%
Musculoskeletal3813%
Dermatological (non-injection-site)248%
Neurological217%
Allergic / Anaphylactic93%
Psychiatric / Neuropsychiatric93%
Cardiac / Cardiovascular83%
Gastrointestinal62%
Respiratory52%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Colorado13
California9
Texas8
Ohio7
Pennsylvania6
Oregon6
New York4
Kentucky4
Illinois3
Missouri3
Minnesota3
Alabama2

Reports by month received

2019-0327
2019-0425
2019-057
2019-068
2019-075
2019-084
2019-091
2019-104
2019-111
2019-121
2020-032
2020-052
2020-071
2021-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.